Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Yacki Hayashi-Tanner"'
Autor:
Yacki Hayashi-Tanner, Peter J. Polewski, Mamatha Gaddam, Nancy R. Fisher, Attila J. Kovacs, David E. Marinier
Publikováno v:
Journal of Geriatric Oncology. 13:1011-1016
Increased immune checkpoint inhibitor (ICI) use in various advanced cancer types has led to a parallel rise in immune-related adverse events (irAEs). Despite widespread use, ICI data in older patients remains limited. We investigate irAE prevalence i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78a8c67dc2ea5ce9f474627e7a2182d1
https://doi.org/10.1016/j.jgo.2022.05.007
https://doi.org/10.1016/j.jgo.2022.05.007
Autor:
Yacki Hayashi-Tanner, John P. Farnen, Dipesh Uprety, Wayne A. Bottner, Lori J Rosenstein, Yazhini Vallatharasu, Richard H. Aster, Peter J Polewski, Amir Bista
Publikováno v:
Am J Hematol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3334bf3c2742160d07b4bd7c186eee8
https://pubmed.ncbi.nlm.nih.gov/30575104
https://pubmed.ncbi.nlm.nih.gov/30575104
Autor:
Yacki Hayashi-Tanner, Attila J. Kovacs, David E. Marinier, Mamatha Gaddam, Peter J Polewski, Nancy R Fisher
Publikováno v:
Journal of Clinical Oncology. 38:e24014-e24014
e24014 Background: Increased use of immune checkpoint inhibitor (ICI) therapy over various cancer types has resulted in a parallel rise in immune-related adverse events (irAEs). There is limited data with regards to understanding irAEs in the elderly
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::316662cc202fa2e91a07e8116309a647
https://doi.org/10.1200/jco.2020.38.15_suppl.e24014
https://doi.org/10.1200/jco.2020.38.15_suppl.e24014